23andMe, a leading genetic testing company, has entered Chapter 11 bankruptcy, struggling significantly after a data breach affected nearly 7 million customers. Following this breach, where sensitive personal information was compromised, customers are eligible to file claims. The company, alongside several subsidiaries, cited declining sales and executive departures as contributing factors to its downfall. Along with these operational issues, costly expansions into digital health yielded little success. Customers must file their claims by July 14, highlighting ongoing consumer mistrust and a challenging road ahead for 23andMe.
23andMe, having recently filed for Chapter 11 bankruptcy, is notifying customers about claims related to a data breach that compromised personal information of nearly 7 million users.
The company's ambitious expansion into digital health, along with declining sales and executive turnover, culminated in a devastating data breach and numerous class action lawsuits.
Collection
[
|
...
]